SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Not yet recruiting · NCT06846424 · Registry updated 2025-02-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube carcinoma, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal carcinoma | Not yet recruiting | Phase 1 | 2025-02-26 | NCT06846424 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Gynecologic Oncology Group | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital Fudan University | Shanghai | China | 38 |